Disease mongering in neurological disorders

Autores
Kochen, Sara Silvia; Córdoba, Marta
Año de publicación
2013
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
“Diseases mongering”, than a simple definition would be enforced "to promote or sell disease". The main and common characteristhics of all these "diseases" is that they are amenable to treatment with drugs. So, the pharmaceutical industry redefining the concept of disease, the normal and pathological. In Neurology exploits the deepest atavistic fears of suffering and death. We select some diseases, the choise was based on lack or weak evidence in definition of disease; or cost benefit of treatment; or the new clasiffication that assign criteria of severity of one disease. In everything this situation implied use of expensive treatments. The entities included, Attention deficit hyperactivity disorder, in adults, Multiple Sclerosis, Mild Cognitive Impairment, Drug Resistant Epilepsy, Amyotrophic lateral sclerosis, Excessive daytime sleepiness/ Chronic Fatigue. In developing countries the impact of this situation is even worse for the scarce resources and inequitable health condition. Health professionals become aware of this situation.
Fil: Kochen, Sara Silvia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; Argentina
Fil: Córdoba, Marta. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; Argentina
Materia
Diseases Mongering
Epilepsy
Neurological Disorders
Treatment
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/17203
Acceder
id CONICETDig_406aab4a57621ed2b5e62e80bf607778
oai_identifier_str oai:ri.conicet.gov.ar:11336/17203
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Disease mongering in neurological disordersKochen, Sara SilviaCórdoba, MartaDiseases MongeringEpilepsyNeurological DisordersTreatmenthttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3“Diseases mongering”, than a simple definition would be enforced "to promote or sell disease". The main and common characteristhics of all these "diseases" is that they are amenable to treatment with drugs. So, the pharmaceutical industry redefining the concept of disease, the normal and pathological. In Neurology exploits the deepest atavistic fears of suffering and death. We select some diseases, the choise was based on lack or weak evidence in definition of disease; or cost benefit of treatment; or the new clasiffication that assign criteria of severity of one disease. In everything this situation implied use of expensive treatments. The entities included, Attention deficit hyperactivity disorder, in adults, Multiple Sclerosis, Mild Cognitive Impairment, Drug Resistant Epilepsy, Amyotrophic lateral sclerosis, Excessive daytime sleepiness/ Chronic Fatigue. In developing countries the impact of this situation is even worse for the scarce resources and inequitable health condition. Health professionals become aware of this situation.Fil: Kochen, Sara Silvia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; ArgentinaFil: Córdoba, Marta. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; ArgentinaScienpress2013-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/17203Kochen, Sara Silvia; Córdoba, Marta; Disease mongering in neurological disorders; Scienpress; Journal of Applied Medical Sciences; 2; 4; 10-2013; 27-332241-23282241-2336enginfo:eu-repo/semantics/altIdentifier/url/https://www.scienpress.com/journal_focus.asp?main_id=71&Sub_id=IV&Issue=979info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:48:19Zoai:ri.conicet.gov.ar:11336/17203instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:48:19.343CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Disease mongering in neurological disorders
title Disease mongering in neurological disorders
spellingShingle Disease mongering in neurological disorders
Kochen, Sara Silvia
Diseases Mongering
Epilepsy
Neurological Disorders
Treatment
title_short Disease mongering in neurological disorders
title_full Disease mongering in neurological disorders
title_fullStr Disease mongering in neurological disorders
title_full_unstemmed Disease mongering in neurological disorders
title_sort Disease mongering in neurological disorders
dc.creator.none.fl_str_mv Kochen, Sara Silvia
Córdoba, Marta
author Kochen, Sara Silvia
author_facet Kochen, Sara Silvia
Córdoba, Marta
author_role author
author2 Córdoba, Marta
author2_role author
dc.subject.none.fl_str_mv Diseases Mongering
Epilepsy
Neurological Disorders
Treatment
topic Diseases Mongering
Epilepsy
Neurological Disorders
Treatment
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv “Diseases mongering”, than a simple definition would be enforced "to promote or sell disease". The main and common characteristhics of all these "diseases" is that they are amenable to treatment with drugs. So, the pharmaceutical industry redefining the concept of disease, the normal and pathological. In Neurology exploits the deepest atavistic fears of suffering and death. We select some diseases, the choise was based on lack or weak evidence in definition of disease; or cost benefit of treatment; or the new clasiffication that assign criteria of severity of one disease. In everything this situation implied use of expensive treatments. The entities included, Attention deficit hyperactivity disorder, in adults, Multiple Sclerosis, Mild Cognitive Impairment, Drug Resistant Epilepsy, Amyotrophic lateral sclerosis, Excessive daytime sleepiness/ Chronic Fatigue. In developing countries the impact of this situation is even worse for the scarce resources and inequitable health condition. Health professionals become aware of this situation.
Fil: Kochen, Sara Silvia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; Argentina
Fil: Córdoba, Marta. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; Argentina
description “Diseases mongering”, than a simple definition would be enforced "to promote or sell disease". The main and common characteristhics of all these "diseases" is that they are amenable to treatment with drugs. So, the pharmaceutical industry redefining the concept of disease, the normal and pathological. In Neurology exploits the deepest atavistic fears of suffering and death. We select some diseases, the choise was based on lack or weak evidence in definition of disease; or cost benefit of treatment; or the new clasiffication that assign criteria of severity of one disease. In everything this situation implied use of expensive treatments. The entities included, Attention deficit hyperactivity disorder, in adults, Multiple Sclerosis, Mild Cognitive Impairment, Drug Resistant Epilepsy, Amyotrophic lateral sclerosis, Excessive daytime sleepiness/ Chronic Fatigue. In developing countries the impact of this situation is even worse for the scarce resources and inequitable health condition. Health professionals become aware of this situation.
publishDate 2013
dc.date.none.fl_str_mv 2013-10
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/17203
Kochen, Sara Silvia; Córdoba, Marta; Disease mongering in neurological disorders; Scienpress; Journal of Applied Medical Sciences; 2; 4; 10-2013; 27-33
2241-2328
2241-2336
url http://hdl.handle.net/11336/17203
identifier_str_mv Kochen, Sara Silvia; Córdoba, Marta; Disease mongering in neurological disorders; Scienpress; Journal of Applied Medical Sciences; 2; 4; 10-2013; 27-33
2241-2328
2241-2336
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.scienpress.com/journal_focus.asp?main_id=71&Sub_id=IV&Issue=979
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Scienpress
publisher.none.fl_str_mv Scienpress
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268917589868544
score 13.13397

Publicaciones similares